BioAge Labs Alternatives & Competitors
12 companies similar to BioAge Labs — We are harnessing the biology of human aging to develop novel targets and therap...
Companies similar to BioAge Labs
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
France
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...
Millbrae, United States
Biomea Fusion
We are creating an entirely new Generation of Precision Medicine against Genetically Defin...
United States
Track all BioAge Labs competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
EOLO PHARMA
Cutting-Edge Pharmacological Treatment for Obesity
San Francisco, United Sta...
Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...
Molecure
Fate can be altered.
Warsaw, Poland
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Boston, United States
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Redwood City, United Stat...
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Oxford, United Kingdom
Mineralys Therapeutics, Inc.
Public, clinical-stage biopharmaceutical company committed to developing best-in-class, no...
United States
NodThera
Treating chronic disease by targeting inflammation at its source
Philadelphia, United Stat...
About BioAge Labs
BioAge Labs, founded in 2015, stands at the forefront of the biopharmaceutical industry, leveraging the biology of human aging to devise novel therapeutic targets for metabolic diseases. Positioned in the United States, this clinical-stage company is actively developing therapeutic product candidates aimed at tackling...
Development of therapies for metabolic diseases, Research on NLRP3 inhibitors, Development of APJ agonists for weight loss, Multi-omics data analysis for aging research
Pharmaceutical companies, Biotech investors, Healthcare providers, Patients with metabolic diseases
Biopharmaceutical, Metabolic Diseases, Human Aging Biology, NLRP3 Inhibitor, Cardiovascular Risk, Retinal Diseases, Preclinical Programs, Drug Discovery, Longevity Data, APJ Agonists, Obesity Treatment, Brain-penetrant Small Molecules, Aging-related Diseases, Clinical-stage Development
B2B, D2C
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches BioAge Labs and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at BioAge Labs on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
